NDC 0078-0470 – Exjade

Deferasirox 500 mg/1 · Tablet, For Suspension · Oral

Human Prescription Drug

Product NDC0078-0470

Product details

Brand name
Exjade
Generic name
Deferasirox
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
Tablet, For Suspension
Route
Oral
Marketing category
NDA · NDA021882
Marketed since
November 30, 2005
Listing expires
December 31, 2027
Pharmacologic class
Iron Chelator

Active ingredients

Uses, dosage, side effects and warnings for Exjade →

Package NDC codes (1)

Package NDCDescriptionSince
0078-0470-1530 TABLET, FOR SUSPENSION in 1 BOTTLE (0078-0470-15)Nov 30, 2005

Other Exjade products